1. "Survivorship Research"
Formats
  1. Journal Article (8900)
  2. Meeting Abstract (5192)
  3. Book Section (571)
  4. Review (357)
  5. Editorial (225)
  6. Research Letter (132)
  7. Conference Paper (104)
  8. Correspondence (91)
  9. Guidelines (85)
  10. Miscellaneous (76)
  11. Book Whole (30)
Groups
  1. Survivorship Research (15763)
  2. Department of Medicine (9202)
  3. Population Sciences Research Program (5670)
  4. Solid Tumor Oncology Division (5184)
  5. Surgery (5131)
  6. Epidemiology and Biostatistics (3598)

More Groups

People
  1. Clifford Hudis (905)
  2. Kenneth Offit (788)
  3. Michael Zelefsky (754)
  4. Sergio Giralt (684)
  5. Mark Robson (676)
  6. Joachim Yahalom (625)

More People

Years
  1. 2025 (231)
  2. 2024 (802)
  3. 2023 (892)
  4. 2022 (906)
  5. 2021 (922)
  6. 2020 (930)

More Years

Publications
  1. Journal of Clinical Oncology (1873)
  2. International Journal of Radiation Oncology, Biology, Physics (908)
  3. Blood (685)
  4. Annals of Surgical Oncology (599)
  5. Cancer Research (333)
  6. Cancer (331)

More Publications

Publishers
  1. Elsevier Inc. (2658)
  2. American Society of Clinical Oncology (2019)
  3. Springer (1542)
  4. Wiley Blackwell (806)
  5. Oxford University Press (787)
  6. American Society of Hematology (748)

More Publishers

Results (15763)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Survivorship in patients with cardiac metastases defined by cardiac magnetic resonance imaging in relation to lesion hypoperfusion
    Meeting Abstract

    Jain, R.; Liberman, N.; Agoglia, H.; Park, M.; Park, R.; Jessurun, J.; Tap, W. D.; Kim, J.; Steingart, R.; Liu, J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Association of cannabis use with real-world time to treatment discontinuation (rwTTD) in patients with advanced cancer initiating immune checkpoint inhibition (ICI)
    Meeting Abstract

    Zylla, D. M.; Knowlton, G.; Gilmore, G.; Pawloski, P. A.; Salz, T.; Kulkarni, A.; Cowger, J.; Kuranz, S.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Skin adverse events of anti-cancer treatments: An examination of drug-AE associations
    Meeting Abstract

    Salah, S.; Kerob, D.; PageĢ€s, C.; Lacouture, M. E.; Sibaud, V.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Patterns, perceptions, and experience with cannabidiol (CBD) after cancer diagnosis
    Meeting Abstract

    Lapen, K.; Mao, J. J.; Raghunathan, N. J.; Jinna, S.; Brens, J.; Hernandez, M.; Korenstein, D.; Salz, T.; Chino, F.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Unmasking ethnic disparities in Asian representation in U.S. oncology training programs
    Meeting Abstract

    Santos, P. M. G.; Chino, F.; Torres, M. A.; Suneja, G.; Deville, C.; Vapiwala, N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Assessing changes in cancer-related financial support needs across three waves of the COVID-19 pandemic
    Meeting Abstract

    Thom, B.; Incudine, A.; Arora, N.; Stivers, T.; Winder, K.; Chino, F.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Enhancing patient clinical streamlining (EPACS) pilot in the breast medicine service at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Amel Riazat-Kesh, Y. J. R.; Miceli, M. R.; Smith, A.; Keenan, K.; Morrison, J.; Magnoli, R.; Strong, V. E.; Traina, T. A.; Sanford, R. A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Ustekinumab for the treatment of immune related cutaneous adverse events (ircAEs)
    Meeting Abstract

    Maier, T.; Gu, S.; Shah, N. J.; Faleck, D. M.; Lacouture, M. E.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Predictors of resistance to trastuzumab deruxtecan (T-DXd) in esophagogastric adenocarcinoma (EGC)
    Meeting Abstract

    Tsai, C.; Chou, J. F.; Biachi de Castria, T.; Tang, L. H.; Ilson, D. H.; Ku, G. Y.; Schultz, N.; Capanu, M.; Janjigian, Y. Y.; Maron, S. B.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Real world treatment patterns and survival by germline BRCA (gBRCA) mutation status in patients with HER2-negative early breast cancer (eBC) in the US community oncology setting: A retrospective observational study
    Meeting Abstract

    Andersen, J. C.; Earla, J. R.; Fulcher, N.; Ndukum, J.; Robert, N. J.; Robson, M. E.; Li, W.; Mejia, J.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save